Overview

Tanezumab In Osteoarthritis Of The Hip Or Knee

Status:
Terminated

Trial end date:
2011-02-04

Target enrollment:

Participant gender:

Summary

The purpose of the study is to test the efficacy and safety of 2 doses of tanezumab compared to oxycodone CR and placebo in patients with osteoarthritis

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Oxycodone
Tanezumab